New Cas9 Enzyme Reduces CRISPR Off-target Effects Without Significant Loss of On-target Activity

Product News   Aug 03, 2017

 
New Cas9 Enzyme Reduces CRISPR Off-target Effects Without Significant Loss of On-target Activity
 
 
FURTHER INFORMATION
 
 
 

Related Product News

UK / Chinese Collaboration to Develop Innovative Technologies for Epigenetics

Product News

Porvair Sciences are teaming up with Suzhou Tianlong Bio Technology Co Ltd (China), together with Swansea University and Xi'an Jiaotong University in a collaborative project entitled, "Automating & Stratification of Epigenetics in Healthcare" that is part of the Innovate UK / Jiangsu Industrial Challenge Programme.

READ MORE

SYGNIS AG Launches TruePrime™ Apoptotic Cell Free DNA Amplification Kit for the Liquid Biopsy Market

Product News

TruePrime™ cfDNA kit offers superior selectivity and preferential amplification. TruePrime™ cfDNA is fully scalable from small to mid-scale programs.

READ MORE

Horizon Reports Expansion of CRISPR License Rights with ERS Genomics

Product News

Breadth of research use rights now expanded to include multiple new species.

READ MORE

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE